200 Participants NeededMy employer runs this trial

CT-Guided PCI for Coronary Artery Disease

(CT-PLAN-PCI Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Minneapolis Heart Institute Foundation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The CT-PLAN PCI trial will evaluate whether CCTA-guided PCI improves procedural efficiency compared with routine PCI (without pre-procedural CCTA-guidance for PCI planning) using procedural time as the primary endpoint. Key secondary outcomes will include contrast volume, radiation dose, fluoroscopy time, resource utilization, and periprocedural outcomes including post-PCI physiology, and peri-procedural myocardial injury measured by high-sensitivity cardiac troponin assays.

Are You a Good Fit for This Trial?

This trial is for adults with coronary artery disease who are scheduled to have a procedure called PCI (angioplasty) to open blocked heart arteries. People with certain health conditions or risks that could interfere with the study may not be able to join.

Inclusion Criteria

At least one moderate-severe coronary stenosis on CCTA with an FFRCT ≤0.80 involving no more than two vessels (target lesion(s) must be FFRCT eligible)
I am scheduled for a non-emergency heart procedure to treat a new blockage in an artery.

Exclusion Criteria

Patients who are pregnant or nursing or plan to be pregnant in the period up to 2 years following the index procedure due to exposure to fluoroscopy
I have had heart bypass surgery before.
I have unstable, high-risk heart symptoms like chest pain or irregular heartbeat.
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-procedural Planning

Pre-procedural planning using CCTA for PCI, including assessment of coronary anatomy and stent planning

1-2 weeks

Treatment

Participants undergo PCI, either CCTA-guided or routine, with procedural time as the primary endpoint

Intra-procedural

Follow-up

Participants are monitored for safety and effectiveness, including incidence of major adverse cardiovascular events

12 months

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares two ways of planning PCI: one group gets a special heart CT scan (CCTA) before their procedure, while the other group has routine care without this scan. The main goal is to see if using CCTA makes the procedure faster and more efficient.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: CT-guided PCIExperimental Treatment1 Intervention
Group II: Routine PCIActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Minneapolis Heart Institute Foundation

Lead Sponsor

Trials
32
Recruited
15,700+

HeartFlow, Inc.

Industry Sponsor

Trials
21
Recruited
32,300+

Shockwave Medical, Inc.

Industry Sponsor

Trials
38
Recruited
10,200+